{"id":"W3011514631","doi":"10.1016/j.jhep.2020.02.033","title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","year":2020,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Toronto Liver Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Intercept Pharmaceuticals","keywords":"Obeticholic acid; Medicine; Placebo; Gastroenterology; Internal medicine; Primary sclerosing cholangitis; Clinical endpoint; Bilirubin; Population; Randomized controlled trial; Agonist; Pathology; Disease; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006667501,0.0001352898,0.001796106,0.0001316409,0.00008964814,0.000009323842,0.0001394644,0.0000687334,0.00007681099],"category_scores_gemma":[0.001029221,0.00009603634,0.0005308906,0.0001043782,0.00008970914,0.0001087474,0.00006036835,0.0002605057,0.000001599278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003933368,"about_ca_system_score_gemma":0.0002259726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001997903,"about_ca_topic_score_gemma":0.000001173844,"domain_scores_codex":[0.998235,0.0003263485,0.0009126611,0.0001142817,0.0002173743,0.0001943701],"domain_scores_gemma":[0.998234,0.0003757853,0.0006980944,0.0001453951,0.0003358252,0.0002108478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9652615,0.003724746,0.009515131,0.0002034619,0.001581352,0.000117088,0.002817353,0.000003781005,0.01072976,0.00001704796,0.001144015,0.004884765],"study_design_scores_gemma":[0.9804049,0.01270589,0.001093973,0.00009475325,0.00242978,0.0002951285,0.0007489093,0.0004796669,0.001167703,0.00003884786,0.0004510162,0.00008943515],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931015,0.002557228,0.0006038226,0.00187746,0.0001928866,0.00147043,0.000011743,0.000009115233,0.0001758345],"genre_scores_gemma":[0.9976009,0.0001479503,0.0005966007,0.001347146,0.0002415307,0.00002538151,0.000004704358,0.00001664751,0.00001912821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0151434,"threshold_uncertainty_score":0.3916248,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04046731378532505,"score_gpt":0.3178747604981493,"score_spread":0.2774074467128242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}